Page last updated: 2024-12-07

o-methylsterigmatocystin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

o-Methylsterigmatocystin (OMST) is a mycotoxin produced by the fungus Aspergillus. It is a structurally related to sterigmatocystin, a known carcinogenic compound. OMST has been found to be mutagenic in bacterial and mammalian cell systems. It has also been shown to be toxic to animals, with studies demonstrating liver damage and immunosuppression. The importance of studying OMST stems from its potential for contamination of food and feed, as well as its possible role in human health issues. Research on OMST focuses on understanding its biosynthesis, toxicity, and mechanisms of action. Studies are also aimed at developing methods for detection and control of this mycotoxin in food and environmental samples.'

Cross-References

ID SourceID
PubMed CID104940
CHEBI ID18171
SCHEMBL ID1055409
MeSH IDM0119135

Synonyms (24)

Synonym
CHEBI:18171
(3ar,12cs)-6,8-dimethoxy-3a,12c-dihydro-7h-furo[3',2':4,5]furo[2,3-c]xanthen-7-one
o-methyl sterigmatocystin
7-o-methylsterigmatocystin
sterigmatocystin, o-methyl-
7h-furo(3',2':4,5)furo(2,3-c)xanthen-7-one, 3a,12c-dihydro-6,8-dimethoxy-, (3ar-cis)-
7h-furo(3',2':4,5)furo(2,3-c)xanthen-7-one, 3a,12c-dihydro-6,8-dimethoxy-, (3ar,12cs)-
C03686
o-methylsterigmatocystin
17878-69-2
8-o-methylsterigmatocystin
LMPK10000003
unii-kzc4vx8l3n
kzc4vx8l3n ,
SCHEMBL1055409
J-011402
methylsterigmatocystin, o-
6,8-dimethoxy-3a,12c-dihydro-7h-furo[3',2':4,5]furo[2,3-c]xanthen-7-one
DTXSID30939117
Q27102869
11,15-dimethoxy-6,8,20-trioxapentacyclo[10.8.0.02,9.03,7.014,19]icosa-1,4,9,11,14(19),15,17-heptaen-13-one
(3s,7r)-11,15-dimethoxy-6,8,20-trioxapentacyclo[10.8.0.02,9.03,7.014,19]icosa-1,4,9,11,14(19),15,17-heptaen-13-one
7h-furo[3',2':4,5]furo[2,3-c]xanthen-7-one, 3a,12c-dihydro-6,8-dimethoxy-, (3ar,12cs)-
(3ar,12cs)-3a,12c-dihydro-6,8-dimethoxy-7h-furo[3',2':4,5]furo[2,3-c]xanthen-7-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sterigmatocystins
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
aflatoxins B1 and G1 biosynthesis218

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (19.05)18.7374
1990's7 (33.33)18.2507
2000's8 (38.10)29.6817
2010's2 (9.52)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.34 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]